Trial Outcomes & Findings for Piloting Prehabilitation Before Abdominal Surgery (NCT NCT03040336)

NCT ID: NCT03040336

Last Updated: 2020-03-10

Results Overview

Recruitment will be expressed as the percentage of eligible patients approached who agree to participate in this pilot study.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

17 participants

Primary outcome timeframe

Baseline

Results posted on

2020-03-10

Participant Flow

Participant milestones

Participant milestones
Measure
Prehabilitation
Standard of care + Prehabilitation Prehabilitation: The 6-week long prehabilitation intervention will include (1) strength and balance training; (2) inspiratory muscle training; and (3) nutritional coaching and supplementation.
Standard of Care
Patient received the standard hospital care
Overall Study
STARTED
10
7
Overall Study
COMPLETED
7
4
Overall Study
NOT COMPLETED
3
3

Reasons for withdrawal

Reasons for withdrawal
Measure
Prehabilitation
Standard of care + Prehabilitation Prehabilitation: The 6-week long prehabilitation intervention will include (1) strength and balance training; (2) inspiratory muscle training; and (3) nutritional coaching and supplementation.
Standard of Care
Patient received the standard hospital care
Overall Study
Death
1
0
Overall Study
Withdrawal by Subject
2
3

Baseline Characteristics

Piloting Prehabilitation Before Abdominal Surgery

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Prehabilitation
n=10 Participants
Standard of care + Prehabilitation Prehabilitation: The 6-week long prehabilitation intervention will include (1) strength and balance training; (2) inspiratory muscle training; and (3) nutritional coaching and supplementation.
Standard of Care
n=7 Participants
Patient received the standard hospital care
Total
n=17 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
Age, Categorical
Between 18 and 65 years
1 Participants
n=99 Participants
1 Participants
n=107 Participants
2 Participants
n=206 Participants
Age, Categorical
>=65 years
9 Participants
n=99 Participants
6 Participants
n=107 Participants
15 Participants
n=206 Participants
Age, Continuous
75.22 years
STANDARD_DEVIATION 7.48 • n=99 Participants
71.71 years
STANDARD_DEVIATION 11.08 • n=107 Participants
73.69 years
STANDARD_DEVIATION 7.86 • n=206 Participants
Sex: Female, Male
Female
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
Sex: Female, Male
Male
10 Participants
n=99 Participants
7 Participants
n=107 Participants
17 Participants
n=206 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
10 Participants
n=99 Participants
7 Participants
n=107 Participants
17 Participants
n=206 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
Race (NIH/OMB)
Asian
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
Race (NIH/OMB)
Black or African American
2 Participants
n=99 Participants
2 Participants
n=107 Participants
4 Participants
n=206 Participants
Race (NIH/OMB)
White
8 Participants
n=99 Participants
5 Participants
n=107 Participants
13 Participants
n=206 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
Region of Enrollment
United States
10 Participants
n=99 Participants
7 Participants
n=107 Participants
17 Participants
n=206 Participants

PRIMARY outcome

Timeframe: Baseline

Population: 54 is the number of patients approached. Only 17 were consented and overall analyzed.

Recruitment will be expressed as the percentage of eligible patients approached who agree to participate in this pilot study.

Outcome measures

Outcome measures
Measure
Approached
n=54 Participants
Patients approached to participate.
Standard of Care
Patient received the standard hospital care
Recruitment Rate
17 Participants

PRIMARY outcome

Timeframe: Baseline

Population: 17 participants were overall analyzed. 10 were randomized to prehab, 7 were randomized to standard of care.

Randomization rate will be expressed as the percentage of eligible patients who agreed to participate who then agreed to be randomized to control or intervention conditions

Outcome measures

Outcome measures
Measure
Approached
n=17 Participants
Patients approached to participate.
Standard of Care
n=17 Participants
Patient received the standard hospital care
Randomization Rate
10 Participants
7 Participants

PRIMARY outcome

Timeframe: Baseline to 90 days postoperatively

Retention rate will be expressed as the percentage of enrolled patients who were retained in the study and completed study procedures. It will be calculated for incremental steps along the study timeline and at the completion of study procedures 90 days postoperatively.

Outcome measures

Outcome measures
Measure
Approached
n=10 Participants
Patients approached to participate.
Standard of Care
n=7 Participants
Patient received the standard hospital care
Retention Rate
7 Participants
4 Participants

PRIMARY outcome

Timeframe: Baseline to Day of Surgery

Population: The compliance rate is only calculated for the prehabilitation arm.

Compliance rates will be expressed as the percentage of total compliance with assigned pehab activities actually completed by patients as recorded in home exercise and nutrition logs and completion of on site exercise sessions.

Outcome measures

Outcome measures
Measure
Approached
n=10 Participants
Patients approached to participate.
Standard of Care
Patient received the standard hospital care
Compliance Rate
Home exercise log
56 percentage of completed activities
Standard Deviation 42.74
Compliance Rate
Nutrition log
10 percentage of completed activities
Standard Deviation 31.62
Compliance Rate
On site exercise sessions
93.6 percentage of completed activities
Standard Deviation 7.60

SECONDARY outcome

Timeframe: Baseline, day of surgery, 90 days postoperatively

Population: All participants that completed the hand grip assessment were analyzed at each completed timepoint.

Grip strength will be measured in kilograms of pressure using a Jamar grip dynamometer

Outcome measures

Outcome measures
Measure
Approached
n=10 Participants
Patients approached to participate.
Standard of Care
n=7 Participants
Patient received the standard hospital care
Grip Strength
Baseline
26.38 kgf/cm2
Standard Deviation 4.99
27.75 kgf/cm2
Standard Deviation 11.19
Grip Strength
Day of Surgery
29.00 kgf/cm2
Standard Deviation 5.38
32.00 kgf/cm2
Standard Deviation 13.88
Grip Strength
90 days
23.75 kgf/cm2
Standard Deviation 4.23
33.63 kgf/cm2
Standard Deviation 11.28

SECONDARY outcome

Timeframe: Baseline, day of surgery, 90 days postoperatively

Population: All participants that completed the pulmonary function assessments were analyzed at each completed timepoint.

Pulmonary function will be measured in terms of maximal inspiratory and expiratory pressures.

Outcome measures

Outcome measures
Measure
Approached
n=10 Participants
Patients approached to participate.
Standard of Care
n=7 Participants
Patient received the standard hospital care
Pulmonary Function
Baseline Max MIP
66.00 cm of water
Standard Deviation 27.20
79.33 cm of water
Standard Deviation 30.81
Pulmonary Function
Day of Surgery Max MIP
70.11 cm of water
Standard Deviation 29.75
90.00 cm of water
Standard Deviation 19.97
Pulmonary Function
90 Day Max MIP
63.17 cm of water
Standard Deviation 32.00
100.00 cm of water
Standard Deviation 11.53
Pulmonary Function
Baseline Max MEP
90.60 cm of water
Standard Deviation 34.97
114.67 cm of water
Standard Deviation 41.56
Pulmonary Function
Day of Surgery Max MEP
108.67 cm of water
Standard Deviation 35.22
112.33 cm of water
Standard Deviation 35.64
Pulmonary Function
90 Day Max MEP
97.67 cm of water
Standard Deviation 30.50
102.75 cm of water
Standard Deviation 19.48

SECONDARY outcome

Timeframe: Baseline, day of surgery, 90 days postoperatively

Population: All participants that completed the blood draw were analyzed at each completed timepoint. Additionally, there was an error in the lab when processing the blood samples, this caused many samples to be evaluated incorrectly. Only correctly analyzed labs were included in this analysis.

Nutrition will be measured by serum prealbumin. Higher scores indicate greater levels of protein. Lower levels indicate the potential of inflammation.

Outcome measures

Outcome measures
Measure
Approached
n=9 Participants
Patients approached to participate.
Standard of Care
n=4 Participants
Patient received the standard hospital care
Serum Prealbumin
Baseline Prealbumin
26.5 mg/dL
Standard Deviation 4.93
29 mg/dL
Standard Deviation 2.83
Serum Prealbumin
Day of Surgery Prealbumin
22.5 mg/dL
Standard Deviation 6.36
25.5 mg/dL
Standard Deviation 2.12
Serum Prealbumin
90 Day Prealbumin
23.6 mg/dL
Standard Deviation 8.44
22 mg/dL
Standard Deviation 0

SECONDARY outcome

Timeframe: Baseline, day of surgery, 90 days postoperatively

Population: All participants that completed the gait speed assessment were analyzed at each completed timepoint.

Gait speed will be measured by using a stopwatch to time how long the patient takes to walk 4 meters.

Outcome measures

Outcome measures
Measure
Approached
n=10 Participants
Patients approached to participate.
Standard of Care
n=7 Participants
Patient received the standard hospital care
Gait Speed
Baseline Gait Speed
0.98 m/s
Standard Deviation 0.30
1.54 m/s
Standard Deviation 0.55
Gait Speed
Day of Surgery Gait Speed
1.00 m/s
Standard Deviation 0.17
1.07 m/s
Standard Deviation 0.15
Gait Speed
90 Day Gait Speed
1.07 m/s
Standard Deviation 0.40
1.21 m/s
Standard Deviation 0.20

SECONDARY outcome

Timeframe: Baseline, day of surgery, 90 days postoperatively

Population: All participants that completed the SPPB assessments were analyzed at each completed timepoint.

This standardized outcome measure asks patients to complete several activities that are scored independently and then aggregated into an overall score ranging from 0-12. Higher scores indicate better physical performance.

Outcome measures

Outcome measures
Measure
Approached
n=10 Participants
Patients approached to participate.
Standard of Care
n=7 Participants
Patient received the standard hospital care
Short Physical Performance Battery (SPPB)
Baseline SPPB
9.13 score on a scale
Standard Deviation 2.30
10.6 score on a scale
Standard Deviation 1.52
Short Physical Performance Battery (SPPB)
Day of Surgery SPPB
10.56 score on a scale
Standard Deviation 0.88
11 score on a scale
Standard Deviation 0
Short Physical Performance Battery (SPPB)
90 Day SPPB
9.8 score on a scale
Standard Deviation 1.79
10.75 score on a scale
Standard Deviation 0.96

SECONDARY outcome

Timeframe: Baseline, day of surgery, 90 days postoperatively

Population: All participants that completed the RAI assessment were analyzed at each completed timepoint.

This recently published frailty index is assessed by a clinician administered questionnaire. The score and reflects frailty-associated mortality risk ranging from 0-81. Higher scores indicate higher risk for post operative complications and other frailty-related outcomes.

Outcome measures

Outcome measures
Measure
Approached
n=10 Participants
Patients approached to participate.
Standard of Care
n=7 Participants
Patient received the standard hospital care
Risk Analysis Index of Frailty (RAI)_questionnaire
Baseline RAI
31.57 score on a scale
Standard Deviation 11.86
24.75 score on a scale
Standard Deviation 0.50
Risk Analysis Index of Frailty (RAI)_questionnaire
Day of Surgery RAI
27.86 score on a scale
Standard Deviation 12.79
29.00 score on a scale
Standard Deviation 5.66
Risk Analysis Index of Frailty (RAI)_questionnaire
90 Day RAI
29.00 score on a scale
Standard Deviation 10.39
26.67 score on a scale
Standard Deviation 2.89

SECONDARY outcome

Timeframe: Baseline, day of surgery, 90 days postoperatively

Population: All participants that completed the Subjective Global Assessment were analyzed at each completed timepoint.

This standardized survey instrument is completed by a trained clinician after assessing a nutrition-specific patient history. The minimum score is 1 and the maximum score is 7. High scores indicate better nourishment.

Outcome measures

Outcome measures
Measure
Approached
n=10 Participants
Patients approached to participate.
Standard of Care
n=7 Participants
Patient received the standard hospital care
7-point Subjective Global Assessment of Nutrition_questionnaire
Baseline Subjective Global Assessment
5.43 score on a scale
Standard Deviation 0.79
6.4 score on a scale
Standard Deviation 0.55
7-point Subjective Global Assessment of Nutrition_questionnaire
Day of Surgery Subjective Global Assessment
5.14 score on a scale
Standard Deviation 1.07
6.00 score on a scale
Standard Deviation 0
7-point Subjective Global Assessment of Nutrition_questionnaire
90 Day Subjective Global Assessment
5.14 score on a scale
Standard Deviation 1.07
6.33 score on a scale
Standard Deviation 0.58

OTHER_PRE_SPECIFIED outcome

Timeframe: 30 and 90 days postoperatively

Population: The mortality questionnaire was completed for all participants still enrolled in the study at the indicated time point.

Postoperative mortality

Outcome measures

Outcome measures
Measure
Approached
n=9 Participants
Patients approached to participate.
Standard of Care
n=4 Participants
Patient received the standard hospital care
Postoperative Mortality
30-days mortality
0 Participants
0 Participants
Postoperative Mortality
90-days mortality
1 Participants
0 Participants

OTHER_PRE_SPECIFIED outcome

Timeframe: Baseline, day of surgery, 90-days postoperatively

Population: Not all participants were analyzed, because this measure requires participants to complete the questionnaire and not all participants did.

Assessment of Quality of Life (AQoL-6D). Utility score ranges from 0 to 1. Higher scores indicate better quality of life.

Outcome measures

Outcome measures
Measure
Approached
n=7 Participants
Patients approached to participate.
Standard of Care
n=3 Participants
Patient received the standard hospital care
Health Related Quality of Life
Baseline
0.72 score on a scale
Standard Deviation 0.09
0.67 score on a scale
Standard Deviation 0.05
Health Related Quality of Life
Day of Surgery
0.68 score on a scale
Standard Deviation 0.08
0.77 score on a scale
Standard Deviation 0.01
Health Related Quality of Life
90-days postoperative
0.75 score on a scale
Standard Deviation 0.09
0.80 score on a scale
Standard Deviation 0.07

OTHER_PRE_SPECIFIED outcome

Timeframe: Day of Surgery and 30-days postoperatively

Population: All participants that completed the assessment were analyzed at each completed timepoint.

AHRQ Surgical Care Survey (SCS). Scores on this scale range from 1 to 3. Lower scores indicate better communication.

Outcome measures

Outcome measures
Measure
Approached
n=9 Participants
Patients approached to participate.
Standard of Care
n=5 Participants
Patient received the standard hospital care
Quality of Surgical Care
Day of Surgery Total Communication
1.33 score on a scale
Standard Deviation 0.37
1.13 score on a scale
Standard Deviation 0.18
Quality of Surgical Care
30-days Total Communication
1.25 score on a scale
Standard Deviation 0.29
1.19 score on a scale
Standard Deviation 0.24

Adverse Events

Prehabilitation

Serious events: 3 serious events
Other events: 0 other events
Deaths: 1 deaths

Standard of Care

Serious events: 2 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Serious adverse events
Measure
Prehabilitation
n=10 participants at risk
Standard of care + Prehabilitation Prehabilitation: The 6-week long prehabilitation intervention will include (1) strength and balance training; (2) inspiratory muscle training; and (3) nutritional coaching and supplementation.
Standard of Care
n=7 participants at risk
Patient received the standard hospital care
Injury, poisoning and procedural complications
Unexpected and unrelated hospitalization
30.0%
3/10 • Number of events 6 • Adverse events were collected for each participant, from the time of enrollment, usually 3-6 weeks prior to surgery, to first final follow up, 90 days after surgery. Adverse events were collected over a time period of approximately four months.
28.6%
2/7 • Number of events 2 • Adverse events were collected for each participant, from the time of enrollment, usually 3-6 weeks prior to surgery, to first final follow up, 90 days after surgery. Adverse events were collected over a time period of approximately four months.
Respiratory, thoracic and mediastinal disorders
Unexpected and unrelated death
10.0%
1/10 • Number of events 1 • Adverse events were collected for each participant, from the time of enrollment, usually 3-6 weeks prior to surgery, to first final follow up, 90 days after surgery. Adverse events were collected over a time period of approximately four months.
0.00%
0/7 • Adverse events were collected for each participant, from the time of enrollment, usually 3-6 weeks prior to surgery, to first final follow up, 90 days after surgery. Adverse events were collected over a time period of approximately four months.

Other adverse events

Adverse event data not reported

Additional Information

Dr. Daniel E Hall

Pittsburgh VA Healthcare System, CHERP

Phone: 4123602016

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place